In addition to this, the global market was worth US$ 479.0 Mn in 2018 and is anticipated to reach US$ 722.0 Mn by 20226. The increasing incidence of ocular diseases, such as glaucoma, age-related macular degeneration, and refractive errors, is driving the ophthalmic laser market. As the drugs for treating ocular diseases is less, the demand for ophthalmic laser devices has come into existence.
Browse Complete Report Details @
The Global Ophthalmic Lasers Market reflects an impressive growth owing to the growing prevalence of refractive errors across the world. According to a report, published by Fortune Business Insights, titled, “Ophthalmic Lasers Market: Global Market Analysis, Insights and Forecast, 2019-2026” the global market is expected to register a CAGR of 5.3% between 2019 and 2026.
Some of the Main Key Players Covered in the Report
- IRIDEX Corporation
- NIDEK CO., LTD.
- Carl Ziess Meditec AG
- Ellex Medical Lasers Ltd.
- TOPCON CORPORATION
- NoIR Laser Company, LLC
Excimer Lasers Gain an Upper Hand Over Other Laser Types
In 2018, the excimer lasers among other types of ophthalmic lasers covered 39.2% of the global market. These lasers are used for procedures such as refractive error correction. Recent technological advancements are expected to boost the segment growth during the forecast period. The demand for ophthalmic laser systems is likely to increase in hospitals, ophthalmic laser centers, among others.
Get Sample PDF [email protected]
- Excimer Lasers
- Femtosecond Lasers
- Nd Yag Lasers
- Diode Lasers
- Selective Laser Trabeculoplasty
- Cataract Treatment
- Glaucoma Treatment
- Refractive Errors Treatment
By End User
- Ophthalmic Laser Centers
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Carl Zeiss’s VisuMax Receives FDA Approval to Bring Innovation in Laser Eye Surgery
The global ophthalmic laser market is semi-consolidated with the presence of three leading players. These players include Lumenis, TOPCON CORPORATION, and Ellex Medical Lasers, Ltd. covered the maximum share in the year 2018. These players are well-recognized and have a robust distribution network in the medical laser segment. Such factors are responsible for the dominance of these players. Several companies are focusing on to launch new products in order to strengthen their distribution channel.
For instance, Novartis AG (Alcon) announced FDA approval for LenSx in March 2018. The product has two indications, one for creating tunnels allowing placement of corneal rings, whereas the other is to create corneal pockets for effective placement of presbyopia-correcting inlays. Another company called Carl Zeiss Meditec AG announced FDA approval for VisuMax femtosecond laser system in September 2016. This system is used to perform small-incision lenticule extraction for refractive correction.
The report profiles some of the leading players functioning in the global ophthalmic laser market. These include IRIDEX Corporation, Ellex Medical Lasers Ltd., NIDEK CO., LTD., Lumibird, TOPCON CORPORATION, NoIR Laser Company, LLC, and Lumenis.
More Trending Topics from Fortune Business Insights: